Dublin, April 21, 2025 (GLOBE NEWSWIRE) -- The "Dental Digital X-Ray Market Report 2025" has been added to ResearchAndMarkets.com's offering. The dental digital X-ray market is experiencing ...

One company to watch right now is Dentsply Sirona (XRAY). XRAY is currently sporting a Zacks Rank of #2 (Buy), as well as a Value grade of A. The stock has a Forward P/E ratio of 8.94. This ...

In this article, we are going to take a look at where Dentsply Sirona Inc. (NASDAQ:XRAY) stands against other Thursday’s top-performing stocks. The stock market extended its winning streak on ...

In this article, we are going to take a look at where DENTSPLY SIRONA Inc. (NASDAQ:XRAY) stands against other most undervalued stocks with smart money ratings. We have passed a quarter into 2025 ...

The new method was made possible by the multiplex imaging tool Phenocycler 2.0, which enabled researchers to visualize a record number of cellular markers within intact bone marrow tissue from ...

A new bone marrow imaging technique could change treatment for cancer, autoimmune disease and musculoskeletal disorders. Indiana University School of Medicine scientists have developed a powerful ...

According to the team, this works even when the separation between the sources is too small for traditional imaging methods to resolve. The precision claims are based on simulations and ...

XRAY is a #2 (Buy) on the Zacks Rank, with a VGM Score of A. It also boasts a Value Style Score of A thanks to attractive valuation metrics like a forward P/E ratio of 8.88; value investors should ...

"A suitable radiotracer that can noninvasively map synucleinopathies through PET imaging will lead to breakthroughs in early diagnosis, monitoring disease progression, and evaluating treatment ...